XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2

Operating Segments (Tables)

9 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

The table below presents certain financial information of our operating segments for the three and nine months ended September 30, 2022 and 2021 (in thousands).

Segment Reporting for the Quarter Ended September 30, 2022

Schedule of Segment Reporting Information

		Treatment				Services				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	8,877			$	9,595			$	18,472	$			—			$	18,472
Intercompany revenues			28				16				44				—				—
Gross profit			1,967				1,103				3,070				—				3,070
Research and development			55				—				55				14				69
Interest income			—				—				—				29				29
Interest expense			(20	)			(2	)			(22	)			(25	)			(47	)
Interest expense-financing fees			—				—				—				(16	)			(16	)
Depreciation and amortization			387				87				474				23				497
Segment income (loss) before income taxes			1,792				725				2,517				(1,514	)			1,003	(2)
Income tax expense			164				15				179				—				179
Segment income (loss)			1,628				710				2,338				(1,514	)			824
Expenditures for segment assets			149				39				188				1				189	(3)

Segment Reporting for the Nine Months Ended September 30, 2022

		Treatment				Services				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	24,749			$	29,093			$	53,842				$  —			$	53,842
Intercompany revenues			28				43				71				—				—
Gross profit			4,168				3,422				7,590				—				7,590
Research and development			179				23				202				43				245
Interest income			—				—				—				69				69
Interest expense			(53	)			—				(53	)			(70	)			(123	)
Interest expense-financing fees			—				—				—				(44	)			(44	)
Depreciation and amortization			1,139				244				1,383				50				1,433
Segment income (loss) before income taxes			1,675				1,524				3,199				(5,028	)			(1,829	)(2)
Income tax benefit			(91	)			(56	)			(147	)			—				(147	)
Segment income (loss)			1,766				1,580				3,346				(5,028	)			(1,682	)
Expenditures for segment assets			819				127				946				1				947	(3)

Segment Reporting for the Quarter Ended September 30, 2021

		Treatment				Services				Medical				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	8,893			$	6,904				—			$	15,797			$	—			$	15,797
Intercompany revenues			220				5				—				225				—				—
Gross profit (negative gross profit)			2,487				(263	)			—				2,224				—				2,224
Research and development			52				18				162				232				11				243
Interest income			—				—				—				—				2				2
Interest expense			(51	)			(1	)			—				(52	)			(25	)			(77	)
Interest expense-financing fees			—				—				—				—				(11	)			(11	)
Depreciation and amortization			319				85				—				404				5				409
Segment income (loss) before income taxes			1,317				(984	)			(162	)			171				(1,626	)			(1,455	)
Income tax expense (benefit)			1				—				—				1				(2,837	)			(2,836	)(4)
Segment income (loss)			1,316				(984	)			(162	)			170				1,211				1,381
Expenditures for segment assets			482				—				—				482				—				482	(6)

Segment Reporting for the Nine Months Ended September 30, 2021

		Treatment				Services				Medical				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	24,094			$	30,981				—			$	55,075			$	—			$	55,075
Intercompany revenues			1,199				44				—				1,243				—				—
Gross profit			4,845				701				—				5,546				—				5,546
Research and development			142				50				311				503				35				538
Interest income			—				—				—				—				23				23
Interest expense			(88	)			(9	)			—				(97	)			(112	)			(209	)
Interest expense-financing fees			—				—				—				—				(28	)			(28	)
Depreciation and amortization			939				255				—				1,194				14				1,208
Segment income (loss) before income taxes			1,669				(1,721	)			(311	)			(363	)			987	(5)			624
Income tax (benefit) expense			(13	)			10				—				(3	)			(2,837	)			(2,840	)(4)
Segment income (loss)			1,682				(1,731	)			(311	)			(360	)			3,824				3,464
Expenditures for segment assets			1,109				14				—				1,123				9				1,132	(6)

⁽¹⁾ Amounts reflect the activity for corporate headquarters not included in the segment information.

⁽²⁾ Includes approximately $1,975,000 recorded as other income under the Employee Retention Credit program under the CARES Act, as amended (see “Note 13 – Employee Retention Credit (“ERC”) below for a discussion of this expected refund amount).

⁽³⁾ Net of financed amount of $0 and $114,000 for the three and nine months ended September 30, 2022, respectively.

⁽⁴⁾ Includes tax benefit recorded in amount of approximately $2,351,000 resulting from release of valuation allowance on the Company’s deferred tax assets.

⁽⁵⁾ Includes approximately $5,381,000 of “Gain on extinguishment of debt” recorded in connection with the Company’s Paycheck Protection Program (“PPP”) Loan which was forgiven by the U.S. Small Business Administration effective June 15, 2021.

⁽⁶⁾ Net of financed amount of $271,000 and $348,000 for the three and nine months ended September 30, 2021, respectively.

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration